{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:19:51Z","timestamp":1776701991752,"version":"3.51.2"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,5,27]],"date-time":"2002-05-27T00:00:00Z","timestamp":1022457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> : Although a previous meta\u2010analysis found that intravenous H<jats:sub>2<\/jats:sub>\u2010receptor antagonists were only weakly beneficial in bleeding gastric ulcer and of no benefit in bleeding duodenal ulcer, patients with ulcer bleeding continue to receive such treatment.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> : To re\u2010evaluate the efficacy of intravenous H<jats:sub>2<\/jats:sub>\u2010receptor antagonists in ulcer re\u2010bleeding, surgery and mortality by updating the previous meta\u2010analysis.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> : After two independent literature searches, randomized, placebo\u2010controlled trials of intravenous H<jats:sub>2<\/jats:sub>\u2010receptor antagonists in bleeding ulcer published between 1984 and 2000 were added to those from the initial meta\u2010analysis. Pooled rates of re\u2010bleeding, surgery and death were re\u2010calculated, together with the relative risk reduction, absolute risk reduction, number needed to treat and Mantel\u2013Haenszel odds ratio.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> : Intravenous H<jats:sub>2<\/jats:sub>\u2010receptor antagonists did not significantly reduce re\u2010bleeding, surgery or death in bleeding duodenal ulcer. There were small but significant reductions in re\u2010bleeding, surgery and death in bleeding gastric ulcer; the absolute risk reductions were 7.2%, 6.7% and 3.2%, respectively.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> : Intravenous H<jats:sub>2<\/jats:sub>\u2010receptor antagonists are of no value in bleeding duodenal ulcer, although they may be mildly beneficial in bleeding gastric ulcer. Because proton pump inhibitors have a greater inhibitory effect on gastric acid secretion than H<jats:sub>2<\/jats:sub>\u2010receptor antagonists, they may be more effective in ulcer bleeding and should be further evaluated for that indication.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2002.01274.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:47:06Z","timestamp":1047354426000},"page":"1137-1142","source":"Crossref","is-referenced-by-count":64,"title":["Meta\u2010analysis: the efficacy of intravenous H<sub>2<\/sub>\u2010receptor antagonists in bleeding peptic ulcer"],"prefix":"10.1111","volume":"16","author":[{"given":"J. E.","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. I.","family":"Leontiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,5,27]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198509123131104"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93078-2"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1991.tb00008.x"},{"key":"e_1_2_9_5_2","first-page":"119","volume-title":"Monographs in Epidemiology and Biostatistics, Vol 24.","author":"Petitti DB","year":"1994"},{"key":"e_1_2_9_6_2","first-page":"A","article-title":"Glossary","volume":"133","author":"Anonymous.","year":"2000","journal-title":"ACP Journal Club"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6977.452"},{"key":"e_1_2_9_8_2","first-page":"147","article-title":"Randomized prospective trial of cimetidine in the treatment of acute upper gastrointestinal haemorrhage","volume":"25","author":"Baltas B","year":"1984","journal-title":"Acta Chir Hung"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1986.01400070103021"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1986.tb02380.x"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199876"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361503"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00812-9"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430501"},{"key":"e_1_2_9_15_2","first-page":"225","article-title":"Optimizing the intragastric pH as a supportive therapy in upper GI bleeding","volume":"69","author":"Brunner G","year":"1996","journal-title":"Yale J Biol Med"},{"key":"e_1_2_9_16_2","first-page":"679","article-title":"The effects of intravenous omeprazole on 24 h gastric secretion in healthy subjects. Comparisons of continuous and intermittent infusions: a pilot study","volume":"3","author":"Sackier IE","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.857_y.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000201217"},{"key":"e_1_2_9_19_2","first-page":"A165(Abstract","article-title":"Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding","volume":"116","author":"Fried R","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_9_20_2","first-page":"A2379(Abstract","article-title":"Comparison of intravenous pantoprazole with intravenous ranitidine in prevention of rebleeding from gastroduodenal ulcers","volume":"49","author":"Duvnjak M","year":"2001","journal-title":"Gut"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2002.01274.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2002.01274.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2002.01274.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:48:41Z","timestamp":1697492921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2002.01274.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,27]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1046\/j.1365-2036.2002.01274.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01274.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,27]]}}}